Indian biopharmaceutical company Biocon posted a 31% year-on-year rise in Q4 FY23 net profit, at INR313 crore ($41.9m), driven by successful biosimilar and research services businesses. The company registered INR239 crore in the same quarter of the prior financial year. Kiran Mazumdar Shaw spoke to ET Now on comopanies performance.
#bioconq4 #bioconquarter4 #bioconrevenue
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► [ Ссылка ]

Subscribe Now To Our Network Channels :-
Times Now : [ Ссылка ]
The NewsHour Debate : [ Ссылка ]

To Stay Updated Download the Times Now App :-
Android Google Play : [ Ссылка ]
Apple App Store : [ Ссылка ]

Social Media Links :-
Twitter - [ Ссылка ]
Facebook - [ Ссылка ]
G+ - [ Ссылка ]
Website - www.etnownews.com

свернуть